CSIMarket Company Name, Ticker, Industry, else..
 
Zenas Biopharma Inc   (NASDAQ: ZBIO)
 

Zenas Biopharma Inc's Suppliers Performance

ZBIO's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
ZBIO Costs vs Sales of Suppliers Growth

• More on ZBIO Suppliers






Zenas Biopharma Inc's Comment on Supply Chain


The company sources raw materials, samples, components, and other materials for its product candidates. Securing alternative suppliers may be challenging in terms of price and availability, and transferring manufacturing processes could require significant time and expense. New manufacturers must comply with quality standards, regulations, and guidelines, which may necessitate additional studies. To meet manufacturing needs for commercializing obexelimab and other product candidates, contract manufacturing organizations (CMOs) will need to scale up production or additional suppliers must be secured. Processes for producing obexelimab drug substance and drug product for commercial supply have been developed and are considered amenable to scale-up.

Zenas Biopharma Inc's Comment on Supply Chain


The company sources raw materials, samples, components, and other materials for its product candidates. Securing alternative suppliers may be challenging in terms of price and availability, and transferring manufacturing processes could require significant time and expense. New manufacturers must comply with quality standards, regulations, and guidelines, which may necessitate additional studies. To meet manufacturing needs for commercializing obexelimab and other product candidates, contract manufacturing organizations (CMOs) will need to scale up production or additional suppliers must be secured. Processes for producing obexelimab drug substance and drug product for commercial supply have been developed and are considered amenable to scale-up.







ZBIO's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Zenas Biopharma Inc 1,702.14 0.00 -484.38 167
SUBTOTAL 0.00 0.00 0.00 -


Sources: Zenas Biopharma Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Zenas Biopharma Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.